Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: MEA Direct-to-Consumer Laboratory Testing Market

4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
5.1. Key Industrial Events (licensing partnerships/mergers & acquisitions)
5.2. Disease Prevalence & Incidence Rate
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Sample Type, 2017–2031
6.3.1. Blood
6.3.2. Urine
6.3.3. Saliva
6.3.4. Others
6.4. Market Attractiveness Analysis, by Sample Type

7. MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Test Type, 2017–2031
7.3.1. Genetic Testing
7.3.1.1. Nutrigenetics Test
7.3.1.1.1. Weight Control
7.3.1.1.2. Lactose Intolerance
7.3.1.1.3. Others
7.3.1.2. Celiac Disease Test
7.3.1.3. Sports & Physical Activity Testing
7.3.1.4. Men’s Health Tests
7.3.1.5. Women’s Health Tests
7.3.1.6. Pregnancy & Prenatal Screening Test
7.3.1.7. General Health Testing
7.3.1.8. Others
7.3.2. Disease Risk Assessment Testing
7.3.2.1. Sexual Health Tests
7.3.2.1.1. HIV
7.3.2.1.2. Chlamydia
7.3.2.1.3. Others
7.3.2.2. Cancer Predisposition Tests
7.3.2.3. Others
7.3.3. CBC
7.3.4. Chronic Disease Testing
7.3.4.1. Diabetes Testing
7.3.4.2. Hypertension
7.3.4.3. Others
7.3.5. COVID-19 Testing
7.3.6. TSH Testing
7.3.7. Others
7.4. Market Attractiveness Analysis, by Test Type

8. MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Provider
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Provider, 2017–2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Specialty Labs
8.3.4. Diagnostic Centers
8.4. Market Attractiveness Analysis, by Provider

9. GCC Countries Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Sample Type, 2017–2031
9.2.1. Blood
9.2.2. Urine
9.2.3. Saliva
9.2.4. Others
9.3. Market Value Forecast, by Test Type, 2017–2031
9.3.1. Genetic Testing
9.3.1.1. Nutrigenetics Test
9.3.1.1.1. Weight Control
9.3.1.1.2. Lactose Intolerance
9.3.1.1.3. Others
9.3.1.2. Celiac Disease Test
9.3.1.3. Sports & Physical Activity Testing
9.3.1.4. Men’s Health Tests
9.3.1.5. Women’s Health Tests
9.3.1.6. Pregnancy & Prenatal Screening Test
9.3.1.7. General Health Testing
9.3.1.8. Others
9.3.2. Disease Risk Assessment Testing
9.3.2.1. Sexual Health Tests
9.3.2.1.1. HIV
9.3.2.1.2. Chlamydia
9.3.2.1.3. Others
9.3.2.2. Cancer Predisposition Tests
9.3.2.3. Others
9.3.3. CBC
9.3.4. Chronic Disease Testing
9.3.4.1. Diabetes Testing
9.3.4.2. Hypertension
9.3.4.3. Others
9.3.5. COVID-19 Testing
9.3.6. TSH Testing
9.3.7. Others
9.4. Market Value Forecast, by Provider, 2017–2031
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Specialty Labs
9.4.4. Diagnostic Centers

10. South Africa Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Sample Type, 2017–2031
10.2.1. Blood
10.2.2. Urine
10.2.3. Saliva
10.2.4. Others
10.3. Market Value Forecast, by Test Type, 2017–2031
10.3.1. Genetic Testing
10.3.1.1. Nutrigenetics Test
10.3.1.1.1. Weight Control
10.3.1.1.2. Lactose Intolerance
10.3.1.1.3. Others
10.3.1.2. Celiac Disease Test
10.3.1.3. Sports & Physical Activity Testing
10.3.1.4. Men’s Health Tests
10.3.1.5. Women’s Health Tests
10.3.1.6. Pregnancy & Prenatal Screening Test
10.3.1.7. General Health Testing
10.3.1.8. Others
10.3.2. Disease Risk Assessment Testing
10.3.2.1. Sexual Health Tests
10.3.2.1.1. HIV
10.3.2.1.2. Chlamydia
10.3.2.1.3. Others
10.3.2.2. Cancer Predisposition Tests
10.3.2.3. Others
10.3.3. CBC
10.3.4. Chronic Disease Testing
10.3.4.1. Diabetes Testing
10.3.4.2. Hypertension
10.3.4.3. Others
10.3.5. COVID-110 Testing
10.3.6. TSH Testing
10.3.7. Others
10.4. Market Value Forecast, by Provider, 2017–2031
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Specialty Labs
10.4.4. Diagnostic Centers

11. Rest of MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Sample Type, 2017–2031
11.2.1. Blood
11.2.2. Urine
11.2.3. Saliva
11.2.4. Others
11.3. Market Value Forecast, by Test Type, 2017–2031
11.3.1. Genetic Testing
11.3.1.1. Nutrigenetics Test
11.3.1.1.1. Weight Control
11.3.1.1.2. Lactose Intolerance
11.3.1.1.3. Others
11.3.1.2. Celiac Disease Test
11.3.1.3. Sports & Physical Activity Testing
11.3.1.4. Men’s Health Tests
11.3.1.5. Women’s Health Tests
11.3.1.6. Pregnancy & Prenatal Screening Test
11.3.1.7. General Health Testing
11.3.1.8. Others
11.3.2. Disease Risk Assessment Testing
11.3.2.1. Sexual Health Tests
11.3.2.1.1. HIV
11.3.2.1.2. Chlamydia
11.3.2.1.3. Others
11.3.2.2. Cancer Predisposition Tests
11.3.2.3. Others
11.3.3. CBC
11.3.4. Chronic Disease Testing
11.3.4.1. Diabetes Testing
11.3.4.2. Hypertension
11.3.4.3. Others
11.3.5. COVID-19 Testing
11.3.6. TSH Testing
11.3.7. Others
11.4. Market Value Forecast, by Provider, 2017–2031
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Specialty Labs
11.4.4. Diagnostic Centers
12. Competition Landscape
12.1. Market Player - Competition Matrix (by tier and size of companies)
12.2. Company Profiles
12.2.1. 23andMe, Inc.
12.2.1.1. Company Description
12.2.1.2. Business Overview
12.2.1.3. Strategic Overview
12.2.1.4. SWOT Analysis
12.2.2. Ancestry
12.2.2.1. Company Description
12.2.2.2. Business Overview
12.2.2.3. SWOT Analysis
12.2.3. CircleDNA
12.2.3.1. Company Description
12.2.3.2. Business Overview
12.2.3.3. SWOT Analysis
12.2.4. Eurofins Scientific
12.2.4.1. Company Description
12.2.4.2. Business Overview
12.2.4.3. Financial Overview
12.2.4.4. SWOT Analysis
12.2.5. Family Tree DNA (Gene by Gene)
12.2.5.1. Company Description
12.2.5.2. Business Overview
12.2.5.3. SWOT Analysis
12.2.6. Laboratory Corporation of America Holdings
12.2.6.1. Company Description
12.2.6.2. Business Overview
12.2.6.3. Financial Overview
12.2.6.4. Strategic Overview
12.2.6.5. SWOT Analysis
12.2.7. Living DNA Ltd.
12.2.7.1. Company Description
12.2.7.2. Business Overview
12.2.7.3. SWOT Analysis
12.2.8. Medichecks.com Ltd.
12.2.8.1. Company Description
12.2.8.2. Business Overview
12.2.8.3. SWOT Analysis
12.2.9. MyHeritage Ltd.
12.2.9.1. Company Description
12.2.9.2. Business Overview
12.2.9.3. SWOT Analysis
12.2.10. MyMedLab, Inc.
12.2.10.1. Company Description
12.2.10.2. Business Overview
12.2.10.3. SWOT Analysis
12.2.11. Quest Diagnostics Incorporated
12.2.11.1. Company Description
12.2.11.2. Business Overview
12.2.11.3. Financial Overview
12.2.11.4. Strategic Overview
12.2.11.5. SWOT Analysis



List of Figures

List of Figures

Figure 01: MEA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 02: MEA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 03: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Blood, 2017–2031

Figure 04: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031

Figure 05: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031

Figure 06: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

Figure 07: MEA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 08: MEA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 09: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Genetic Testing, 2017–2031

Figure 10: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Disease Risk Assessment Testing, 2017–2031

Figure 11: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by CBC, 2017–2031

Figure 12: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Chronic Disease Testing, 2017–2031

Figure 13: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by COVID-19 Testing, 2017–2031

Figure 14: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by TSH Testing, 2017–2031

Figure 15: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

Figure 16: MEA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 17: MEA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 18: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Hospitals, 2017–2031

Figure 19: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Clinics, 2017–2031

Figure 20: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Specialty Labs, 2017–2031

Figure 21: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Diagnostic Centers, 2017–2031

Figure 22: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 23: GCC Countries Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 24: GCC Countries Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 25: GCC Countries Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 26: GCC Countries Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 27: GCC Countries Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 28: GCC Countries Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 29: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 30: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 31: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 32: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 33: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 34: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 35: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

List of Tables

List of Tables

Table 01: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 02: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 03: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 04: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 05: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 06: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 07: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 08: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 09: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 10: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 11: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 12: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 13: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 14: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 15: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 16: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 17: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 18: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 19: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 20: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 21: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 22: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 23: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 24: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 25: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 26: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 27: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 28: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 29: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 30: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 31: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 32: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031